Text Size

Nutrition Effects on Fatigue During Tennis Playing

This study has been completed.
Sponsor:
Collaborators:
Service de Médecine du Sport et des Explorations Fonctionnelles - CHU G Montpied - Clermont-Ferrand
Laboratoire BAPS - Université Blaise Pascal - Clermont-Ferrand
Information provided by:
Lescuyer Laboratory
ClinicalTrials.gov Identifier:
NCT01353872
First received: May 13, 2011
Last updated: NA
Last verified: May 2011
History: No changes posted

May 13, 2011
May 13, 2011
October 2010
May 2011   (final data collection date for primary outcome measure)
peripheral fatigue measured by surface electromyographic (EMG) signal from the right triceps muscle [ Time Frame: 3 matches (1.5 days) ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Nutrition Effects on Fatigue During Tennis Playing
Effects of Ingestion of Different Sports Drinks on Fatigue During Playing Tennis

The main objective of this study is to investigate the effects of ingestion of different sports drinks (Nutrattente / Nutraperf / Nutrarecup) on fatigue induced by a tennis tournament simulation.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Fatigue
  • Dietary Supplement: Nutrattente / Nutraperf / Nutrarecup
    500 mL of Nutrattente before each match 500 mL/h of Nutraperf during each match 250 mL of Nutrarecup after each match
  • Dietary Supplement: Nutrattente placebo / Nutraperf placebo / Nutrarecup placebo
    500 mL of Nutrattente placebo before each match 500 mL/h of Nutraperf placebo during each match 250 mL of Nutrarecup placebo after each match
  • Experimental: Sports Drinks
    3 drinks : Nutrattente (before each match) / Nutraperf (during each match) / Nutrarecup (after each match)
    Intervention: Dietary Supplement: Nutrattente / Nutraperf / Nutrarecup
  • Placebo Comparator: Placebo
    3 drinks : Nutrattente placebo (before each match) / Nutraperf placebo(during each match) / Nutrarecup placebo (after each match)
    Intervention: Dietary Supplement: Nutrattente placebo / Nutraperf placebo / Nutrarecup placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
8
May 2011
May 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • About 18 to 35 years (inclusive) Subject has a stable weight for at least three months before the start of the study
  • Subject able and willing to comply with the protocol and agreeing to give their consent in writing
  • Subject affiliated with a social security scheme
  • Subject willing to be included in the national register of volunteers who lend themselves to biomedical research
Male
18 Years to 35 Years
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01353872
2010-A00724-35
Yes
Peltier, Lescuyer Laboratory
Lescuyer Laboratory
  • Service de Médecine du Sport et des Explorations Fonctionnelles - CHU G Montpied - Clermont-Ferrand
  • Laboratoire BAPS - Université Blaise Pascal - Clermont-Ferrand
Study Director: Sebastien Peltier, PhD Lescuyer Laboratory
Lescuyer Laboratory
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP